The following is a list of the twelve largest health care companies ranked here by revenue as of March 2010[update] according to their released 2009 annual reports.
| Rank |
Company |
Country |
Total Revenues (USD billions) |
Total Revenues (reported currency in millions) |
Change 09/08 (%) |
Net income/ (loss) (reported currency in millions) |
Change 09/08 (%) |
R&D Expenses (reported currency in millions) |
Change 09/08 (%) |
Fortune 500 Ranking[1] |
| 1 |
Johnson & Johnson[2] |
United States |
61.90[3] |
$61,897 |
-2.9 |
$12,266 |
-5.3 |
6,986 |
-7.8 |
103 |
| 2 |
Pfizer[4] |
United States |
50.01[3] |
$50,009 |
3.5 |
8,635 |
6.6 |
7,845 |
-1.3 |
152 |
| 3 |
Roche[5] |
Switzerland |
47.35[3] |
49,051 CHF |
7.5 |
8,510 CHF |
-21.5 |
9,874 CHF |
11.6 |
171 |
| 4 |
GlaxoSmithKline[6] |
United Kingdom |
45.83[3] |
£28,368 |
16.5 |
£5,669 |
20.3 |
£4,106 |
11.5 |
168 |
| 5 |
Novartis[7] |
Switzerland |
44.27[3] |
$44,267 |
6.8 |
$8,454 |
3.6 |
$7,469 |
3.5 |
183 |
| 6 |
Sanofi[8] |
France |
41.99[3] |
€29,306 |
6.3 |
€8,471 |
17.9 |
€4,583 |
0.2 |
181 |
| 7 |
AstraZeneca[9] |
UK/Sweden |
32.81[10] |
$32,804 |
3.8 |
$7,544 |
23.1 |
$4,409 |
-14.9 |
268 |
| 8 |
Abbott Laboratories[11] |
United States |
30.76[10] |
$30,765 |
4.2 |
5,746 |
21.4 |
2,744 |
2.1 |
294 |
| 9 |
Merck & Co.[12] |
United States |
27.43[10] |
$27,428 |
15.0 |
$13,024 |
64.2 |
$5,800 |
20.8 |
378 |
| 10 |
Bayer HealthCare[13] |
Germany |
22.30 |
€15,988 |
3.8 |
€1,696 |
38.8 |
€1,845 |
5.9 |
154 |
| 11 |
Eli Lilly[14] |
United States |
21.84[15] |
$21,836 |
7.2 |
$4,328 |
N/A |
N/A |
N/A |
455 |
| 12 |
Bristol-Myers Squibb[16] |
United States |
18.81[17] |
$18,808 |
6.2 |
$4,420 |
19.9 |
3,647 |
3.8 |
435 |
Some data have not been audited yet. Bayer has additional revenue not included here. The missing parts of the table will be added as more data are released by the companies.
The following is a list of the twelve largest healthcare companies ranked by revenue as of July 2009[update] in the Fortune Global 500.[1]
| Rank[1] |
Company |
Country |
Total Revenues (USD millions) |
Net income/ (loss) (USD millions) |
Employees |
| 1 |
Johnson & Johnson |
United States |
63,747.0[18] |
12,949.0 |
118,700 |
| 2 |
Pfizer |
United States |
48,296.0[19] |
8,104.0 |
81,800 |
| 3 |
GlaxoSmithKline |
United Kingdom |
44,654.0[20] |
8,438.6 |
99,003 |
| 4 |
Roche |
Switzerland |
44,267.5[21] |
8,288.1 |
80,080 |
| 5 |
Sanofi-Aventis |
France |
42,179.0[22] |
5,636.7 |
98,213 |
| 6 |
Novartis |
Switzerland |
41,459.0[23] |
8,195.0 |
96,717 |
| 7 |
AstraZeneca |
United Kingdom/Sweden |
31,601.0[24] |
6,101.0 |
65,000 |
| 8 |
Abbott Laboratories |
United States |
29,527.6[25] |
4,880.7 |
68,838 |
| 9 |
Merck |
United States |
23,850.3[26] |
7,808.4 |
55,200 |
| 10 |
Wyeth |
United States |
22,833.9[27] |
4,417.8 |
47,426 |
| 11 |
Bristol-Myers Squibb |
United States |
21,366.0[28] |
5,247.0 |
35,000 |
| 12 |
Eli Lilly |
United States |
20,378.0[29] |
(2,071.9) |
40,500 |
The following is a list of the 49 largest companies involved in pharmaceutical and biotech industry ranked by healthcare revenue as of 2008[update].[30] Some companies (e.g., Bayer) has additional revenue not included here.[31][32]
| Rank[30] |
Company |
Country |
Total Revenues (USD millions) |
Healthcare R&D 2008 (USD millions) |
Net income/ (loss) 2008 (USD millions) |
Employees 2008 |
| 1 |
Pfizer[33] (with Wyeth[34]) |
United States |
70,696 |
11,318 |
14,111 |
137,127 |
| 2 |
Johnson & Johnson |
United States |
63,747 |
NA |
10,576 |
119,200 |
| 3 |
Hoffmann–La Roche |
Switzerland |
43,970 |
NA |
8,135 |
78,604 |
| 4 |
Novartis |
Switzerland |
41,460 |
NA |
11,946 |
98,200 |
| 5 |
GlaxoSmithKline |
United Kingdom |
40,424 |
6,373 |
10,432 |
103,483 |
| 6 |
Sanofi-Aventis |
France |
40,328 |
NA |
7,204 |
99,495 |
| 7 |
AstraZeneca |
United Kingdom/Sweden |
31,601 |
NA |
5,959 |
67,400 |
| 8 |
Abbott Laboratories[35] |
United States |
29,527 |
2,688 |
4,880 |
68,697 |
| 9 |
Merck & Co. |
United States |
23,850 |
4,678 |
7,808 |
74,372 |
| 10 |
Bristol-Myers Squibb |
United States |
19,977 |
NA |
2,165 |
42,000 |
| 11 |
Eli Lilly and Company |
United States |
18,634 |
NA |
2,953 |
40,600 |
| 12 |
Boehringer Ingelheim |
Germany |
16,959 |
1,977 |
2,163 |
43,000 |
| 13 |
Takeda Pharmaceutical Co. |
Japan |
15,697 |
1,620 |
2,870 |
15,000 |
| 14 |
Bayer [36] |
Germany |
15,407 |
3,770 |
6,448 |
108,600 |
| 15 |
Amgen |
United States |
14,771 |
3,366 |
3,166 |
48,000 |
| 16 |
Genentech |
United States |
13,400 |
15773 |
3,640 |
33,500 |
| 17 |
Baxter International |
United States |
12,300 |
614 |
1,397 |
38,428 |
| 18 |
Teva Pharmaceutical Industries |
Israel |
11,080 |
495 |
546 |
26,670 |
| 19 |
Astellas Pharma |
Japan |
10,701 |
1,435 |
1,122 |
23,613 |
| 20 |
Daiichi Sankyo |
Japan |
9,682 |
1,459 |
671 |
20,100 |
| 21 |
Novo Nordisk |
Denmark |
9,081 |
1,063 |
1,922 |
26,575 |
| 22 |
Procter & Gamble |
United States |
8,964 |
NA |
10,340 |
29,258 |
| 23 |
Eisai |
Japan |
5,583 |
926 |
604 |
14,993 |
| 24 |
Merck KGaA |
Germany |
5,175 |
772 |
1,258 |
13,900 |
| 25 |
Alcon |
United States |
4,897 |
512 |
1,348 |
13,500 |
| 26 |
SINOPHARM |
China |
4,700 |
498 |
1249 |
9700 |
| 27 |
Akzo Nobel |
Netherlands |
4,694 |
741 |
1,449 |
13,000 |
| 28 |
UCB |
Belgium |
4,426 |
1,024 |
492 |
12,741 |
| 29 |
Nycomed |
Switzerland |
4,264 |
NA |
-105 |
10,533 |
| 30 |
Forest Laboratories |
United States |
3,442 |
941 |
454 |
9,649 |
| 31 |
Solvay |
Belgium |
3,268 |
533 |
1,026 |
9,000 |
| 32 |
Genzyme |
United States |
3,187 |
650 |
-17 |
8,477 |
| 33 |
Allergan |
United States |
3,063 |
1,056 |
-127 |
8,423 |
| 34 |
Gilead Sciences |
United States |
3,026 |
384 |
-1,190 |
6,772 |
| 35 |
CSL |
Australia |
2,788 |
161 |
454 |
6,400 |
| 36 |
Chugai Pharmaceutical Co. |
Japan |
2,787 |
467 |
328 |
5,962 |
| 37 |
Biogen Idec |
United States |
2,683 |
718 |
218 |
5,907 |
| 38 |
Bausch & Lomb |
United States |
2,292 |
197 |
15 |
5,830 |
| 39 |
Taiho Pharmaceutical Co. |
Japan |
2,069 |
244 |
132 |
5,756 |
| 40 |
King Pharmaceuticals |
United States |
1,989 |
254 |
289 |
5,191 |
| 41 |
Watson Pharmaceuticals |
United States |
1,979 |
131 |
-445 |
5,126 |
| 42 |
Mitsubishi Pharma |
Japan |
1,945 |
403 |
208 |
5,111 |
| 43 |
Shire |
United Kingdom |
1,797 |
387 |
278 |
4,958 |
| 44 |
Cephalon |
United States |
1,764 |
403 |
145 |
4,913 |
| 45 |
Dainippon Sumitomo Pharma |
Japan |
1,763 |
350 |
193 |
3,750 |
| 46 |
Kyowa Hakko |
Japan |
1,698 |
268 |
108 |
2,895 |
| 47 |
Shionogi |
Japan |
1,640 |
320 |
159 |
2,868 |
| 48 |
Mylan Laboratories |
United States |
1,612 |
104 |
217 |
2,800 |
| 49 |
H. Lundbeck |
Denmark |
1,552 |
329 |
186 |
2,515 |
Alphabetical listing [edit]
It is limited to those companies notable enough to have articles in Wikipedia.
See also [edit]
References [edit]
 Pharmaceutical industry in the United States
|
|
| Companies |
|
|
| Regulatory bodies |
|
|
| Professional bodies |
|
|
| Miscellaneous |
|
|
| Books |
|
|
| Lists |
|
|
| Related templates |
|
|
| Related categories |
|
|
|
|
|
|
|
|
| Apparel |
|
|
| Food and drink production |
|
|
| Food service |
|
|
| Manufacturing |
|
|
| Media |
|
|
| Retail |
|
|
| Science and technology |
|
|
| Services |
|
|
| Transport |
|
|